Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Women with PCOS are more likely to have impaired glucose tolerance and type 2 diabetes, especially if they are Asian or obese.

Insulin sensitizers may slightly reduce hirsutism but are less effective than other treatments.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

People with alopecia areata often have other health issues like skin diseases, metabolic syndrome, stomach infections, lupus, anemia, thyroid problems, mental health issues, vitamin D deficiency, and hearing and eye problems.

Lower SHBG levels may increase the risk of PCOS.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Panax ginseng is generally safe with mild side effects and may have health benefits, but more research is needed.

Quercetin may help with PCOS symptoms, but more research is needed.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Dutasteride more effectively treats hair loss than finasteride, but may increase risk of altered libido.

Vertex pattern hair loss linked to higher prostate cancer risk.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

COVID-19 can cause skin issues like chilblains and rashes, which may help in early detection, especially in patients without other symptoms.

Hair transplantation may work for some types of scarring alopecia, but results vary and more research is needed.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

The review highlights the need for more research on transgender dermatology, the role of dermatologists in gender affirmation, and the effects of hormone therapy on skin and hair.

PRP therapy may increase hair density in pattern hair loss without serious side effects, but more research is needed.

Intralesional corticosteroids work best for mild alopecia areata, and DPCP works best for moderate to severe cases.

Stem cell therapy helps heal burn wounds, especially second-degree burns, by promoting blood vessel growth and reducing inflammation.

Finasteride and dutasteride increase sexual dysfunction risk by 1.57 times in male hair loss treatment.

Botulinum toxin's effectiveness for treating scalp alopecia is not well-supported due to insufficient data.

Cyclosporine combined with corticosteroids is more effective for severe alopecia areata than cyclosporine alone.

Valproic acid increases the risk of hair loss more than other drugs, especially in migraine patients, and lamotrigine may be a safer alternative.

Combination therapies work better than single treatments for hair loss.

Ketoconazole may help regrow hair and increase follicle size, but more research needed.

Lupus patients' body image issues significantly affect their mental health and need more support.

COVID-19 patients often have skin issues like chilblain-like lesions and rashes, which can help in early diagnosis and sometimes indicate severe illness.

Home-based skin care devices are generally safe and effective for hair removal, promoting hair growth, treating wrinkles and acne, but results for psoriasis treatment are mixed.